Dual effects of morphine on permeability and apoptosis of vascular endothelial cells: Morphine potentiates lipopolysaccharide-induced permeability and apoptosis of vascular endothelial cells

Journal of Neuroimmunology

Volumn 146, Issue 1-2, 2004, Pages 13-21

  Liu, Hsien Ching ^a   Anday, Jenine K ^a   House, Steven D ^b   Chang, Sulie L ^a  

^a SETON HALL UNIVERSITY   (United States)

^b ELON UNIVERSITY   (United States)

Author keywords

Apoptosis; Fas; Lipopolysaccharide; Morphine; Permeability; Vascular endothelial cells

Indexed keywords

FAS ANTIGEN; LIPOPOLYSACCHARIDE; MORPHINE; MORPHINE SULFATE;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CAPILLARY PERMEABILITY; CARDIOVASCULAR SYSTEM; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CELL TYPE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; METABOLISM; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR ENDOTHELIUM;

EID: 0346732389     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.09.016     Document Type: Article

References (36)

1. Baba M., Ryozo O., Saeki K. Enhancement of blood-brain barrier permeability to sodium fluorescein by stimulation of mu opioid receptors in mice. Arch. Pharm. 337:1988;423-428.
2. Bailey J., Solnica-Krezel L., Anderson R.W., Dee J. A developmental mutation (npfL1) resulting in cell death in Physarum polycephalum. J. Gen. Microbiol. 138(Pt 12):1992;2575-2588.
3. Bannerman D.D., Goldblum S.E. Endotoxin induces endothelial barrier dysfunction through protein tyrosine phosphorylation. Am. J. Physiol. 273:1997;L217-L226.
4. Chang S.L. Morphine affects the neuro-immune axis and enhances the permeability across the vascular endothelial cell barriers. NIDA Res. Monogr. 181:2001;84-85.
5. Chang S.L., Felix B., Jiang Y., Fiala M. Actions of endotoxin and morphine. Adv. Exp. Med. Biol. 493:2001;187-196.
6. Cheng J., Zhou T., Liu C., Shapiro J.P., Brauer M.J., Kiefer M.C., Barr P.J., Mountz J.D. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 263:1994;1759-1762.
7. Darville M.I., Eizirik D.L. Cytokine induction of fas gene expression in insulin-producing cells requires the transcription factors NF-kB and C/EBP. Diabetes. 50:2001;1741-1748.
8. Dimmeler S., Brinkmann S., Neugebauer E. Endotoxin-induced changes of endothelial cell viability and permeability: protective effect of a 21-aminosteroid. Eur. J. Pharmacol. 287:1995;257-261.
9. Dyrhol-Riise A.M., Stent G., Rosok B.I., Voltersvik P., Olofsson J., Asjo B. The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissue during highly active antiretroviral therapy. Clin. Immunol. 101:2001;169-179.
10. Farber E. Programmed cell death: necrosis versus apoptosis. Mod. Path. 7:1994;605-609.
11. Fiala M., Looney D.J., Stins M., Way D.D., Zhang L., Gan X., Chiappelli F., Schweitzer E.S., Shapshak P., Weinand M., Graves M.C., Witte M., Kim K.S. TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol. Med. 3:1997;553-564.
12. Hilburger M.E., Adler M.W., Truant A.L., Meissler J.J. Jr., Satishchandran V., Rogers T.J., Eisenstein T.K. Morphine induces sepsis in mice. J. Infect. Dis. 176:1997;183-188.
13. Hoek J.B. Intracellular signal transduction and the control of endothelial permeability. Lab. Invest. 67:1992;1-4.
14. Kevil C.G., Payne D.K., Mire E., Alexander J.S. Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J. Biol. Chem. 273:1998;15099-15103.
15. Li D., Mrsny R.J. Oncogenic Raf-1 disrupts epithelial tight junctions via downregulation of occludin. J. Cell Biol. 148:2000;791-800.
16. Loh H.H., Liu H.C., Cavalli A., Yang W., Chen Y.F., Wei L.N. Mu opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Brain Res. Mol. Brain Res. 54:1998;321-326.
17. MacFarlane A.S., Peng X., Meissler J.J. Jr., Rogers T.J., Geller E.B., Adler M.W., Eisenstein T.K. Morphine increases susceptibility to oral Salmonella typhimurium infection. J. Infect. Dis. 181:2000;1350-1358.
18. Maier C., Hildebrandt J., Klinger R., Henrich-Eberl C., Lindena G. Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain - results of a double-blind placebo-controlled trial (MONTAS). Pain. 97:2002;223-233.
19. Malik A.A., Radhakrishnan N., Reddy K., Smith A.D., Singhal P.C. Morphine-induced macrophage apoptosis modulates migration of marcrophage: use of in vitro model of urinary tract infection. J. Endourol. 16:2002;605-610.
20. Midis G.P., Shen Y., Owen-Schaub L.B. Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy. Cancer Res. 56:1996;3870-3874.
21. Morley P., Small D.L., Murray C.L., Mealing G.A., Poulter M.O., Durkin J.P., Stanimirovic D.B. Evidence that functional glutamate receptors are not expressed on rat or human cerebromicrovascular endothelial cells. J. Cereb. Blood Flow Metab. 18:1998;396-406.
22. Muschen M., Warskulat U., Douillard P., Gilbert E., Haussinger D. Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal rat liver cells. Hepatology. 17:1998;200-208.
23. Nottet H.S. Interactions between macrophages and brain microvascular endothelial cells: role in pathogenesis of HIV-1 infection and blood-brain barrier function. J. Neurovirology. 5:1999;659-669.
24. Roy S., Charboneau R.G., Barke R.A. Morphine synergizes with lipopolysaccharide in a chronic endotoxemia model. J. Neuroimmunol. 95:1999;107-114.
25. Rubin L.L., Staddon J.M. The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 22:1999;11-28.
26. Simonato M. The neurochemistry of morphine addiction in the neocortex. Trends Pharmacol. Sci. 17:1996;410-415.
27. Sharp B.M. Opioid receptor expression and intracellular signaling by cells involved in host defense and immunity. Adv. Exp. Med. Biol. 521:2003;98-105.
28. Trump B.F., Berezesky I.K., Chang S.H., Phelps P.C. The pathways of cell death: oncosis, apoptosis, and necrosis. Toxicol. Pathol. 25:1997;82-88.
29. Vidal E.L., Patel N.A., Wu G., Fiala M., Chang S.L. Interleukin-1 induces the expression of mu opioid receptors in endothelial cells. Immunopharmacology. 38:1998;261-266.
30. Wang J., Charboneau R., Barke R.A., Loh H.H., Roy S. Mu-opioid receptor mediates chronic restraint stress-induced lymphocyte apoptosis. J. Immunol. 169:2002;3630-3636.
31. Widlak P., Palyvoda O., Kumala S., Garrard W.T. Modeling apoptotic chromatin condensation in normal cell nuclei. Requirement for intranuclear mobility and actin involvement. J. Biol. Chem. 277:2002;21683-21690.
32. Yin D., Mufson R.A., Wang R., Shi Y. Fas-mediated cell death promoted by opioids. Nature. 397:1999;218.
33. Yu X., Mao X., Blake A.D., Li W.-X., Chang S.L. Morphine and endomorphins differentially regulates mu opioid receptor mRNA in SHSY-5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther. 306(2):2003;1-8.
34. Zadina J.E., Chang S.L., Ge L.-J., Kastin A.J. Mu opiate receptor downregulation by morphine and upregulation by naloxone in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther. 617:1993;123-130.
35. Zadina J.E., Harrison L.M., Ge L.-J., Kastin A.J., Chang S.L. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther. 270:1994;1086-1096.
36. Zietz C., Hotz B., Sturzl M., Rauch E., Penning R., Lohrs U. Aortic endothelium in HIV-1 infection: chronic injury, activation, and increased leukocyte adherence. Am. J. Pathol. 149:1996;1887-1898.